Innovative Diagnostic Laboratory

Innovative Diagnostic Laboratory is a national clinical reference lab specializing in personalized blood-based testing to help find, understand, and address cancer risk. IDL’s mission is to provide a comprehensive menu of traditional and advanced clinical evidence-based blood tests that aid in early cancer detection. Currently IDL offers risk assessment blood tests for the three most prevalent cancer types including lung (EarlyCDT-Lung), colon (ColonSentry) and prostate (Prostate Health Index, PHI). IDL is actively in-licensing and commercializing an array of DNA, RNA, protein and autoantibody blood-based cancer diagnostic tests to address early detection of all major types of cancer.